The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Alexandra Lansky
Showing 1-20 of 41 articles
Revascularisation, periprocedural events and survival – and the survival of the randomised controlled trial
Lansky A,
Ahmad Y
March 20, 2023 | 10.4244/EIJ-E-23-00004
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial
Jagielak D,
Targonski R,
Frerker C,
Abdel-Wahab M,
Wilde J,
Werner N,
Lauterbach M,
Leick J,
Grygier M,
Misterski M,
Erglis A,
Narbute I,
Witkowski A,
Adam M,
Frank D,
Gatto F,
Schmidt T,
Lansky A
September 20, 2022 | 10.4244/EIJ-D-22-00238
Abluminal groove-filled biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent: three-year results of the TARGET All Comers trial
Saito Y,
Kelbæk H,
Xu B,
Hussain Y,
Anderson R,
Schächinger V,
Zheng M,
Wijns W,
Baumbach A,
Lansky A
July 20, 2021 | 10.4244/EIJ-D-20-00344
Training and validation of a deep learning architecture for the automatic analysis of coronary angiography
Du T,
Xie L,
Zhang H,
Liu X,
Wang X,
Chen D,
Xu Y,
Sun Z,
Zhou W,
Song L,
Guan C,
Lansky A,
Xu B
May 16, 2021 | 10.4244/EIJ-D-20-00570
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group
Kunadian V,
Chieffo A,
Camici P,
Berry C,
Escaned J,
Maas A,
Prescott E,
Karam N,
Appelman Y,
Fraccaro C,
Buchanan G,
Manzo-Silberman S,
Al-Lamee R,
Regar E,
Lansky A,
Abbott J,
Badimon L,
Duncker D,
Mehran R,
Capodanno D,
Baumbach A
January 20, 2021 | 10.4244/EIJY20M07_01
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI
Stefanini G,
Alfonso F,
Barbato E,
Byrne R,
Capodanno D,
Colleran R,
Escaned J,
Giacoppo D,
Kunadian V,
Lansky A,
Mehilli J,
Neumann F,
Regazzoli D,
Sanz-Sanchez J,
Wijns W,
Baumbach A
December 4, 2020 | 10.4244/EIJ-D-20-00487
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determination
Lansky A,
Shah T,
Wijns W,
Stefanini G,
Farb A,
Kaplan A,
Xu B,
Pietras C,
Velazquez E,
Serruys P,
Mahfoud F,
Baumbach A
November 20, 2020 | 10.4244/EIJV16I10A147
A pilot study with the TriGUARD 3 cerebral embolic protection device
Magalhaes P,
Kooistra N,
Leenders G,
Margolis P,
Lansky A,
Kraaijeveld A,
Voskuil M,
Stella P
August 7, 2020 | 10.4244/EIJ-D-19-00741
Clinical outcome after interventions with paclitaxel-coated balloons: a PCR statement
Lansky A,
Cremonesi A,
Scheller B,
James S,
Grubman D,
Fajadet J,
Sauguet A,
Micari A,
Sarno G,
Bosiers M,
Baumbach A,
Wijns W
February 20, 2020 | 10.4244/EIJV15I14A220
Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
Chang C,
Kogame N,
Onuma Y,
Byrne R,
Capodanno D,
Windecker S,
Morel M,
Cutlip D,
Krucoff M,
Stone G,
Lansky A,
Mehran R,
Spitzer E,
Fraser A,
Baumbach A,
Serruys P
January 17, 2020 | 10.4244/EIJ-D-19-00552
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All Comers
Baumbach A,
Lansky A,
Onuma Y,
Asano T,
Johnson T,
Anderson R,
Kiemeneij F,
Zeng M,
van Royen N,
Slagboom T,
Vlachojannis G,
Serruys P,
Wijns W
November 20, 2018 | 10.4244/EIJ-D-18-00226
TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy
Lansky A,
Ghare M,
Tchétché D,
Baumbach A
September 7, 2018 | 10.4244/EIJ-D-18-00454
Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry
Baumbach A,
Zaman A,
West N,
O'Kane P,
Egred M,
Johnson T,
Wheatcroft S,
Bowles R,
de Belder A,
Bouras G,
Lansky A,
Hill J,
Mathur A,
De Belder M,
Banning A
January 19, 2018 | 10.4244/EIJ-D-17-00886
EXCEL and NOBLE: stents or surgery for left main stem stenosis?
Mangiacapra F,
Maeng M,
Cayla G,
Lansky A,
Meier P,
Kolh P
August 4, 2017 | 10.4244/EIJV13I5A94
Will PIONEER AF-PCI change my practice?
Ukena C,
Leonardi S,
Palmerini T,
Lansky A,
Montalescot G,
Valgimigli M
August 4, 2017 | 10.4244/EIJV13I5A95
The SURTAVI study: TAVI for patients with intermediate risk
Jones D,
Tchétché D,
Forrest J,
Hellig F,
Lansky A,
Moat N
August 4, 2017 | 10.4244/EIJV13I5A97
Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation Club
Collet C,
Onuma Y,
Cavalcante R,
Grundeken M.J,
Généreux P,
Popma J,
Costa R,
Stankovic G,
Tu S,
Reiber J,
Aben J,
Lassen J,
Louvard Y,
Lansky A,
Serruys P
May 15, 2017 | 10.4244/EIJ-D-16-00932
Embolic protection devices in transcatheter aortic valve implantation
van Gils L,
Baumbach A,
Himbert D,
Lansky A,
Vahanian A,
Van Mieghem N
May 3, 2017 | 10.4244/EIJV11I2A45
Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry
Iñiguez A,
Brener S,
Jimenez V,
Maehara A,
Mintz G,
Xu K,
Weisz G,
Lansky A,
De Bruyne B,
Serruys P,
Stone G
April 20, 2016 | 10.4244/EIJV11I13A285
Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome
Hassanin A,
Brener S,
Lansky A,
Xu K,
Stone G
July 20, 2015 | 10.4244/EIJY14M08_05
1
2
3
Latest news
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
#EIJonAir - Renal denervation in the management of hypertension
March 22, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke